BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21031137)

  • 1. Two mouse models for recoverin-associated autoimmune retinopathy.
    Lu Y; He S; Jia L; Khan NW; Heckenlively JR
    Mol Vis; 2010 Oct; 16():1936-48. PubMed ID: 21031137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cytotoxic T lymphocyte antigen 4 (CTLA4) signaling and locally applied steroid on retinal dysfunction by recoverin, cancer-associated retinopathy antigen.
    Maeda A; Maeda T; Liang Y; Yenerel M; Saperstein DA
    Mol Vis; 2006 Aug; 12():885-91. PubMed ID: 16917481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recoverin-associated retinopathy: a clinically and immunologically distinctive disease.
    Whitcup SM; Vistica BP; Milam AH; Nussenblatt RB; Gery I
    Am J Ophthalmol; 1998 Aug; 126(2):230-7. PubMed ID: 9727517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo.
    Adamus G; Machnicki M; Elerding H; Sugden B; Blocker YS; Fox DA
    J Autoimmun; 1998 Oct; 11(5):523-33. PubMed ID: 9802939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-associated retinopathy induced by both anti-recoverin and anti-hsc70 antibodies in vivo.
    Ohguro H; Ogawa K; Maeda T; Maeda A; Maruyama I
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3160-7. PubMed ID: 10586938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal dysfunction in cancer-associated retinopathy is improved by Ca(2+) antagonist administration and dark adaptation.
    Ohguro H; Ogawa K; Maeda T; Maruyama I; Maeda A; Takano Y; Nakazawa M
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2589-95. PubMed ID: 11581204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenously administered anti-recoverin antibody alone does not pass through the blood-retinal barrier.
    Kim JH; Kim JH; Kim DH; Park WY; Kim KW; Yu YS
    Korean J Ophthalmol; 2011 Jun; 25(3):189-95. PubMed ID: 21655045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of retinal expression of vascular cell adhesion molecule (VCAM-1) during experimental autoimmune uveitis.
    Makhoul M; Dewispelaere R; Relvas LJ; Elmaleh V; Caspers L; Bruyns C; Willermain F
    Exp Eye Res; 2012 Aug; 101():27-35. PubMed ID: 22749846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the inner and outer retinal layers after acute increase of the intraocular pressure in adult albino Swiss mice.
    Cuenca N; Pinilla I; Fernández-Sánchez L; Salinas-Navarro M; Alarcón-Martínez L; Avilés-Trigueros M; de la Villa P; Miralles de Imperial J; Villegas-Pérez MP; Vidal-Sanz M
    Exp Eye Res; 2010 Aug; 91(2):273-85. PubMed ID: 20650699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuated glial reactions and photoreceptor degeneration after retinal detachment in mice deficient in glial fibrillary acidic protein and vimentin.
    Nakazawa T; Takeda M; Lewis GP; Cho KS; Jiao J; Wilhelmsson U; Fisher SK; Pekny M; Chen DF; Miller JW
    Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2760-8. PubMed ID: 17525210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplanted olfactory ensheathing cells reduce retinal degeneration in Royal College of Surgeons rats.
    Huo SJ; Li YC; Xie J; Li Y; Raisman G; Zeng YX; He JR; Weng CH; Yin ZQ
    Curr Eye Res; 2012 Aug; 37(8):749-58. PubMed ID: 22691022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional significance of recoverin localization in multiple retina cell types.
    McGinnis JF; Stepanik PL; Jariangprasert S; Lerious V
    J Neurosci Res; 1997 Nov; 50(3):487-95. PubMed ID: 9364334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Paraneoplastic Autoimmune Retinopathy: The First Case Report in Korea.
    Choi EY; Kim M; Adamus G; Koh HJ; Lee SC
    Yonsei Med J; 2016 Mar; 57(2):527-31. PubMed ID: 26847311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of serum anti-retinal antibodies in the Chinese patients with presumed autoimmune retinopathy.
    Zeng HY; Liu Q; Peng XY; Cao K; Jin SS; Xu K
    Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1759-1764. PubMed ID: 31119427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive morphological changes and impaired retinal function associated with temporal regulation of gene expression after retinal ischemia/reperfusion injury in mice.
    Kim BJ; Braun TA; Wordinger RJ; Clark AF
    Mol Neurodegener; 2013 Jun; 8():21. PubMed ID: 23800383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of complement component 3 (C3) from an adenovirus leads to pathology in the murine retina.
    Cashman SM; Desai A; Ramo K; Kumar-Singh R
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3436-45. PubMed ID: 21357400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptotic retinal cell death induced by antirecoverin autoantibodies of cancer-associated retinopathy.
    Adamus G; Machnicki M; Seigel GM
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):283-91. PubMed ID: 9040460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of anti-recoverin autoantibodies in cancer-associated retinopathy.
    Adamus G; Guy J; Schmied JL; Arendt A; Hargrave PA
    Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2626-33. PubMed ID: 7688357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.
    Weleber RG; Watzke RC; Shults WT; Trzupek KM; Heckenlively JR; Egan RA; Adamus G
    Am J Ophthalmol; 2005 May; 139(5):780-94. PubMed ID: 15860281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-amyloid deposition and functional impairment in the retina of the APPswe/PS1DeltaE9 transgenic mouse model of Alzheimer's disease.
    Perez SE; Lumayag S; Kovacs B; Mufson EJ; Xu S
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):793-800. PubMed ID: 18791173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.